Roche Pharma expands partnership with Cipla
Under this agreement, Cipla will be responsible for the marketing and distribution of Roche’s key trademark oncology drugs in the Indian market.
Cipla to buy 22% stake in GoApptiv for $1.19mn
The deal will help Cipla to expand the reach of its key brands in tier-3 plus towns.
Indian companies take off in EU
The civil aviation sector was at the heart of the bond between India and the European Union (EU) in recent weeks. India clears aviation MoU with Poland The Union Cabinet of India, chaired by the Prime Minister Narendra Modi, has given its approval for signing the memorandum of understanding (MoU) between India and Poland for the Promotion of Civil Aviation Cooperation. The MoU, which will be for a term of five years, will be signed on behalf of the two [...]
Indian pharma firm acquires UK’s Actavis to beat Brexit gloom
Beats Mylan, Novartis, Torrent, Aurobindo to the post. Promoter says hungry for more
Almost inarguably, October 5th 2016, a Wednesday was the biggest day in the life of 53 year old Binish Hasmukh Chudgar, the highly low profile vice chairman of Ahmedabad based Intas Pharmaceuticals. That day in central London, Intas snapped up Israeli generic drug maker Teva’s assets in UK and Ireland—Actavis UK Ltd and Actavis Ireland Ltd—in a record $ 764 million deal (Rs 5083 crore) out muscling bigger global rivals like Mylan and Novartis or domestic competition like Aurobindo pharma and Torrent Pharmaceuticals in a bidding process that lasted over 6 months.
India-US walk together for economic growth
Against the backdrop of Indian Prime Minister Narendra Modi’s visit to the US in June, here is a very brief snapshot of some of the recent trends in the India US economic ties over the past few weeks.
Top Indian pharma companies
Indian pharmaceutical industry has been and continues to be a great ambassador for India. Here are some of the companies that are flying the tricolour high globally in this sector.